C
OLMA icon

Covestor’s Olema Pharmaceuticals OLMA Stock Holding History

Covestor’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
5
-11
-69% -$245 ﹤0.01% 2628
2025
Q4 		$0 Hold
16
– – ﹤0.01% 2604
2025
Q3 		$0 Hold
16
– – ﹤0.01% 2618
2025
Q2 		$0 Sell
16
-1
-6% -$4 ﹤0.01% 2591
2025
Q1 		$0 Buy
17
+10
+143% +$50 ﹤0.01% 2581
2024
Q4 		$0 Hold
7
– – ﹤0.01% 2588
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2590
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2601
2024
Q1 		$0 Buy
+7
New +$90 ﹤0.01% 2589
2022
Q1 		– Sell
-15
Closed – – 2334
2021
Q4 		$0 Buy
+15
New +$311 ﹤0.01% 2241

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Covestor's OLMA Position: Q1 2026 in Review

Covestor reduced its Olema Pharmaceuticals (OLMA) stake by 69% in Q1 2026, selling an estimated $245 and leaving 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2628.

Covestor first reported a position in OLMA in Q4 2021 and has held it in 10 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Covestor held 5 shares of Olema Pharmaceuticals worth $0 as of Q1 2026.
  • Covestor sold 11 Olema Pharmaceuticals shares in Q1 2026, an estimated $245.
  • Olema Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2628 holding.
  • Covestor first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.